Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestinal Fistula | 1 | 2021 | 44 | 0.820 |
Why?
|
| Skin Ulcer | 1 | 2021 | 77 | 0.810 |
Why?
|
| Authorship | 1 | 2020 | 53 | 0.730 |
Why?
|
| Virtual Reality | 1 | 2018 | 34 | 0.650 |
Why?
|
| Preceptorship | 1 | 2018 | 35 | 0.640 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 340 | 0.640 |
Why?
|
| Crohn Disease | 1 | 2021 | 351 | 0.630 |
Why?
|
| Gastroenterology | 1 | 2020 | 195 | 0.610 |
Why?
|
| Biological Products | 1 | 2021 | 274 | 0.610 |
Why?
|
| Manikins | 1 | 2018 | 137 | 0.600 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 249 | 0.590 |
Why?
|
| Teaching | 1 | 2018 | 243 | 0.560 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 375 | 0.540 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 85 | 0.540 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 363 | 0.540 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 323 | 0.480 |
Why?
|
| Cost of Illness | 1 | 2017 | 498 | 0.470 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 941 | 0.440 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 860 | 0.430 |
Why?
|
| Caregivers | 1 | 2017 | 677 | 0.390 |
Why?
|
| Colonoscopy | 3 | 2015 | 518 | 0.270 |
Why?
|
| Colonic Polyps | 2 | 2015 | 209 | 0.210 |
Why?
|
| Biological Factors | 1 | 2021 | 45 | 0.190 |
Why?
|
| Infliximab | 1 | 2021 | 130 | 0.190 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 78 | 0.180 |
Why?
|
| Editorial Policies | 1 | 2020 | 87 | 0.180 |
Why?
|
| Adenoma | 2 | 2015 | 716 | 0.170 |
Why?
|
| Drug Monitoring | 1 | 2021 | 333 | 0.170 |
Why?
|
| Barrett Esophagus | 1 | 2024 | 569 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2020 | 417 | 0.150 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 1058 | 0.150 |
Why?
|
| Nadolol | 1 | 2016 | 38 | 0.140 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 87 | 0.140 |
Why?
|
| Propranolol | 1 | 2016 | 156 | 0.140 |
Why?
|
| Ascites | 1 | 2016 | 198 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 1538 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 255 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 343 | 0.120 |
Why?
|
| Proctoscopy | 1 | 2013 | 17 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 552 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 426 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 72 | 0.110 |
Why?
|
| Adenomatous Polyps | 1 | 2013 | 45 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 737 | 0.110 |
Why?
|
| Comorbidity | 2 | 2016 | 2352 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 509 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 605 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 573 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 451 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2017 | 548 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 4988 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 3168 | 0.090 |
Why?
|
| Age Factors | 2 | 2016 | 5377 | 0.090 |
Why?
|
| Humans | 12 | 2024 | 261506 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 1000 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 3578 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 4938 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2027 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 1390 | 0.070 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 1202 | 0.070 |
Why?
|
| Optical Fibers | 1 | 2024 | 37 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2016 | 9244 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2016 | 6869 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4557 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 4971 | 0.050 |
Why?
|
| Male | 5 | 2020 | 123000 | 0.050 |
Why?
|
| United States | 2 | 2016 | 15433 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 33 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 51 | 0.050 |
Why?
|
| Female | 4 | 2020 | 141928 | 0.050 |
Why?
|
| Risk Factors | 1 | 2016 | 17523 | 0.040 |
Why?
|
| Middle Aged | 4 | 2017 | 86204 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1648 | 0.040 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 170 | 0.030 |
Why?
|
| Proctoscopes | 1 | 2013 | 2 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 77950 | 0.030 |
Why?
|
| Colonoscopes | 1 | 2013 | 22 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2016 | 37905 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 70117 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 752 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 551 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 126 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 142 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 590 | 0.030 |
Why?
|
| Microscopy | 1 | 2013 | 182 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 557 | 0.030 |
Why?
|
| Video Recording | 1 | 2013 | 267 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 671 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 2139 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 467 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 769 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2013 | 561 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 670 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4298 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 1011 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 1054 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 1258 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 1081 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1503 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 4320 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4892 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 4744 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 12221 | 0.010 |
Why?
|
| Heart Failure | 1 | 2016 | 2516 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 12873 | 0.010 |
Why?
|